IMC Chicago’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

IMC Chicago’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-18,732	Closed	-$1.55M	–	3942
2025 Q2	$1.55M	Sell	18,732 -55,522	-75%	-$4.43M	﹤0.01%	2191
2025 Q1	$6.02M	Buy	+74,254	New	+$6.64M	﹤0.01%	1130
2024 Q3	–	Sell	-17,194	Closed	-$1.59M	–	3087
2024 Q2	$1.59M	Buy	+17,194	New	+$1.54M	﹤0.01%	1713
2020 Q4	–	Sell	-15,296	Closed	-$1.7M	–	1118
2020 Q3	$1.7M	Sell	15,296 -83,370	-84%	-$9.35M	﹤0.01%	613
2020 Q2	$11M	Buy	+98,666	New	+$9.72M	0.02%	248
2020 Q1	–	Sell	-135,454	Closed	-$12.9M	–	932
2019 Q4	$12.9M	Sell	135,454 -185,376	-58%	-$16M	0.03%	182
2019 Q3	$24.5M	Buy	+320,830	New	+$26.7M	0.08%	85

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

IMC Chicago's XBI Position: Q3 2025 in Review

IMC Chicago sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2025, closing a stake of 18,732 shares — an estimated $1.55M sold.

IMC Chicago first reported a position in XBI in Q3 2019 and held it in 7 quarters. The position peaked at $24.5M in Q3 2019. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

IMC Chicago reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2025 after selling out during the quarter.
IMC Chicago sold 18,732 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $1.55M.
IMC Chicago first reported a position in State Street SPDR S&P Biotech ETF in Q3 2019 and held it in 7 quarters.
IMC Chicago's State Street SPDR S&P Biotech ETF position peaked at $24.5M in Q3 2019.
656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on IMC Chicago's 13F filing for Q3 2025, filed 4 Nov 2025.